Allan Jonathan 4

What Happened

• Allan Jonathan, General Counsel & Corporate Secretary of Stoke Therapeutics (STOK), sold a total of 9,293 shares in open-market transactions on March 20, 2026, generating approximately $313,038 in proceeds. The filing shows two disposals: 8,692 shares at a weighted average price of $33.64 (≈ $292,359) and 601 shares at a weighted average price of $34.41 (≈ $20,679). These were reported as sales (S), not purchases.

Key Details

• Transaction date: 2026-03-20; Form 4 filed: 2026-03-24 (filed four days after the trade date; the filing does not show a late-filing flag).
• Transaction type: Open market sales (S).
• Shares sold: 8,692 and 601 (total 9,293 shares); total reported proceeds ≈ $313,038.
• Prices: reported as weighted averages. Footnotes disclose price ranges: $33.33–$34.28 for the larger block and $34.34–$35.12 for the smaller block.
• Footnotes: filing states the transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.
• Shares owned after transaction: not specified in the information provided in your summary.

Context

• These were outright sales reported by an officer and executed under a pre-established 10b5-1 plan, which is commonly used to automate insider trading and reduce timing concerns. Sales are routine disposals and do not, by themselves, indicate the insider’s private view of the company’s outlook.